Rocuronium Bromide Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Rocuronium Bromide Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Feb 15, 2023.

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-3189-10
Dosage Form
Injection
Presentation
Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10)
Initial Posting
Feb 15, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.